Pegasus Investments Real Estate Advisory and ParaSell, Inc., as exclusive representatives for the Seller, are pleased to offer investors the opportunity to acquire the fee-simple interest in a long-term, net-leased medical property tenanted by one of the largest pharmaceutical companies in the world, Takeda Pharmaceutical Company, Ltd. (NYSE:TAK), located in Green Bay, Wisconsin (“the Property”). Originally constructed as a ground-up, build-to-suit facility for BioLife Plasma Services, a subsidiary of Takeda, in 2013, the Property has been operating continuously for over a decade. In a strong display of long-term commitment, the tenant recently executed a lease extension, a favorable signal that this location performs exceptionally well. With Takeda as the lease guarantor and a long-term lease in place, investors are offered a stable, high-credit income stream from a seasoned operator at a top-performing location ranked in the top 13% nationally by Placer.ai. BioLife Plasma Services is a subsidiary of Takeda, Japan’s largest pharmaceutical company and one of the top 10 globally, with $31.3 billion in annual revenue and investment-grade credit ratings from both Moody’s: Baa1 and S&P: BBB+. BioLife operates over 270 high-tech plasma centers across the US and Europe, supplying essential plasma-derived therapies used to treat rare and serious diseases. The collection center at this Property benefits from a large and loyal donor base, driven in part by the site’s close proximity to several higher education institutions, including Northeast Wisconsin Technical College and University of Wisconsin–Green Bay, which together contribute to a student population exceeding 30,000. The specialized nature of these facilities, requiring costly medical-grade buildouts and stringent FDA licensing, makes plasma centers extremely “sticky” assets that rarely relocate or close. Strategically positioned along a major retail corridor on Highway 54 and just off US 41, the Property is surrounded by high-traffic neighbors, including Walmart (ranked in the top 12% of locations nationally), Sam’s Club, and Oneida Casino. The 3.12-acre parcel provides ample parking and flexibility for future operational needs. Beyond the tenant and real estate fundamentals, Green Bay itself has been recognized as the #1 Best Place to Live in the US for 2024, supported by affordable living, a strong job market, and a strong educational infrastructure. As global demand for plasma-derived therapies continues to significantly outpace supply, and with high barriers to entry in the sector, this offering presents a rare opportunity to acquire an irreplaceable medical asset with long-term cash flow, credit tenancy, and recession-resilient demand drivers in a top-performing Midwest market.